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Abstract: Lyngbyabellin M is a non-ribosomal peptide synthetase/polyketide synthase 
derived metabolite isolated from the cyanobacterium M. bouillonii displaying thiazole 
rings and a distinct chlorinated octanoic acid chain. Its absolute configuration was 
proposed based on the comparison of its spectroscopic data with those of other 
representatives of this family of marine natural products, as well as degradation and 
derivatization studies. Here the first total synthesis of (+)-lyngbyabellin M is described 
based on the coupling of three key intermediates: two chiral thiazole moieties and an anti 
hydroxycarboxylic acid prepared stereoselectively via a boron enolate mediated aldol 
reaction directed by Masamune’s chiral auxiliary. 
Keywords: lyngbyabellin M; total synthesis; chiral thiazoles; stereoselective anti aldol 
 
1. Introduction 
Marine natural products represent an untapped source of structurally diverse and biologically 
relevant molecules and have inspired novel compounds that have entered clinical trials, and some have 
been approved by the Food and Drug Administration (USA). The widespread use of genome 
sequencing is expected to contribute to increase the number of marine natural products in the 
medicinal chemistry pipeline [1]. 
Cyanobacteria are a rich source of biologically active natural compounds, and over the last years  
it has been recognized that many of the natural products isolated from marine animals such as  
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sponges, tunicates and bryozoans are, in fact, produced by symbiotic cyanobacteria. The majority of  
cyanobacteria metabolites are products from either the non-ribosomal polypeptide (NRP) or the mixed 
polyketide-non-ribosomal polypeptide biosynthetic pathways [2]. A particular pharmacological feature 
of the marine cyanobacterial compounds is their ability to act as microtubule and actin disruptors with 
dolastatins 10 and 15 being two of the earliest representatives [3]. 
The findings that many marine natural products structurally resembling those produced by terrestrian 
microorganisms could be produced by marine bacteria or fungi led to the challenge of providing 
sufficient amounts of the natural products in order to unravel their biological properties, not only 
because of their small natural abundance, but also due to problems associated with their collection and 
re-collection [1]. In several cases, limitations on natural supplies require chemical synthesis to come 
into the scene as the structures elucidated by spectroscopic techniques need to be independently 
confirmed. Additionally, usually natural sources are not adequate for in vivo and structure-activity 
relationship studies [4]. 
The lyngbyabellins are a family of non-ribosomal peptide synthetase/polyketide synthase derived 
metabolites displaying thiazole rings and a distinct chlorinated octanoic acid chain produced by the 
genus Moorea sp. (formerly Lyngbya sp.). Lyngbyabellins A and B were isolated in 2000 from  
Lyngbya majuscula [5,6] and their structures have been confirmed by total synthesis (Figure 1) [7–9]. 
By now, 12 other lyngbyabellins have been reported from marine cyanobacteria. Recently, Choi and 
coworkers reported the isolation of five new representatives of the lyngbyabellin family which were  
named as lyngbyabellins K–N (1 and 2, respectively) from marine cyanobacterium M. bouillonii  
(PAL 8/3/09-1) [10]. 
 
Figure 1. Cont.  
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Figure 1. Chemical structures of lyngbyabellins A, B, K, M and Dolabellin. 
Lyngbyabellin K (3) differs from lyngbyabellins A and B (1 and 2, respectively) as it does not 
contain the macrolactam/macrolactone ring displaying a bis macrolactone ring instead and it features a 
2,3-anti relationship in the dichlorooctanoic acid moiety while lyngbyabellin M (4) corresponds to the 
open chain form (cleavage of the C-16-oxygen bond) of lyngbyabellin K (3). Dolabellin (5) is a 
cytotoxic bisthiazole metabolite isolated by Sone and coworkers from the Japanese sea hare  
D. auricularia with syn relative configuration in the dichlorooctanoic acid chain and opposite 
configuration at C-20 in comparison to lyngbyabellin M (4) [11–13]. At this juncture, it is still unclear 
whether lyngbyabellin M (4) is a natural compound or an isolation artifact. The relative configuration 
of lyngbyabellin K (3) was assigned based on spectroscopic data and its absolute configuration was 
established as 2S,3S,14R,20S from X-ray anomalous dispersion data. Lyngbyabellin M (4) was 
proposed to be of the same enantiomeric series as lyngbyabellin K (3) based on the similarities 
observed in the 13C-NMR shifts at most of the signals and similar optical rotation. Additionally, the 
configuration at C-2 and C-3 was confirmed by NMR analyses of the corresponding bis-Mosher esters 
and the absolute configuration of the hydroxy isovaleric residue was established after GC-MS 
comparison of the methyl ester obtained by hydrolysis of an authentic sample [10]. 
In this paper we present our synthetic approach to lyngbyabellin M (4) which allowed the 
confirmation of its 2S,3S,14R,20S configuration as proposed in the isolation studies. 
2. Results and Discussion 
Our approach to lyngbyabellin M (4) relies on the disconnection at the two ester bonds which 
simplifies its preparation to the synthesis of three chiral fragments A–C (Scheme 1). 
 
Scheme 1. Retrosynthetic analysis for lyngbyabellin M (4). 
Mar. Drugs 2015, 13 3312 
 
 
Chiral thiazole A (Scheme 2) was prepared from condensation of (S)-cysteine ethyl ester 
hydrochloride (6) with (R)-isopropylidene glyceraldehyde (7), followed by MnO2 oxidation of the 
intermediate thiazolidine, according to the methodology described by Iwakawa and coworkers for the 
corresponding methyl ester, to afford 3,4-disubstituted thiazole 8 which underwent acetonide 
deprotection to provide thiazole A in 36% overall yield and specific optical rotation [α]D20 = +59 
(MeOH, 1.15) [11–13]. 
 
Scheme 2. Synthesis of thiazole A. 
As to the preparation of thiazole B, a modification of the Hantzch synthesis was employed to  
prepare 13, following the procedure described by Schmidt and coworkers (Scheme 3). Accordingly,  
the reaction of thioamide 12, readily obtained from (S)-valine (9), with ethyl bromopyruvate, followed 
by dehydration of the intermediate upon treatment with trifluoroacetic anhydride (TFAA) at 0 °C 
afforded thiazole 13 as white solid ([α]D25 = −37.0 (c 0.90, CHCl3); [α]D25 = −38.6 (c 1.09, CHCl3)) [14]. 
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Scheme 3. Synthesis of thiazole 13.  
Methanolysis of thiazole 13 required a detailed investigation of the reaction conditions in order to 
avoid extensive racemization (Table 1). Initially, we carried out the hydrolysis/transesterification step 
according to the e procedure in the literature which provided the desired methyl ester in 70% yield but 
its optical rotation [α]D25 = −25.0 (c 0.65, CHCl3) was slightly lower than the one previously reported  
([α]D25 = −31.2 (c 0.61,CHCl3)) [11–13]. Other hydrolytic conditions were tested and, in our hands, the 
best one proved to be the use of dibutyltin oxide in refluxing methanol [15] which afforded the desired 
fragment B in 71% yield and [α]D25 = −27.0 (c 0.70, CHCl3 ). Despite the less than optimal optical purity 
for intermediate B, we decided to move on in our synthetic plan as fragment B would be coupled with 
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fragment C which was expected to be prepared in high enantiomeric ratio. In the event, the undesired 
diastereoisomer obtained after the coupling of fragments B and C would be removed by 
chromatography, affording the desired ester 25 in pure form. 
Table 1. Hydrolysis conditions for the preparation of fragment B. 
 
Entry Conditions Yield (%) [α]D25 (c, CHCl3)
1 MeONa/MeOH, rt, 4 h 85 −25 (0.78) 
2 K2CO3, MeOH, reflux, 2 h 70 −25 (0.65) 
3 
(i) LiOH.H2O, MeOH, rt, 1 h  
(ii) TMSCH2N2, THF, rt, 20 min 
34 −20 (0.66) 
4 Bu2SnO, MeOH, reflux, 12 h 71 −27 (0.78) 
The preparation of gem-dichloro aldehyde 17 was initially investigated via the nucleophilic 
substitution reaction of iodide 14 [16,17] with the lithium anion derived from 1,1-dichloroethane to 
afford 15, followed by removal of the tetrahydropyranyl group and oxidation of the primary alcohol in 
16 (Scheme 4). However, this was not a practical solution as the gem-dichloro pyranyl ether 15 was 
obtained in 25% yield at most. 
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Scheme 4. Synthesis of aldehyde 17.  
The best solution came with the preparation of gem-dichloro alkene 19 in 56% yield (two steps) 
from ketone 18 using the oxidation of the corresponding hydrazone by CuCl2 as described by Takeda 
and coworkers [18]. Hydroboration-oxidation sequence, followed by oxidation of primary alcohol 16 
secured preparation of gem-dichloro aldehyde 17 in 32% overall yield (Scheme 5). 
 
Scheme 5. Alternative synthesis of aldehyde 17.   
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The construction of carboxylic acid C was then accomplished using the anti-selective  
boron-mediated asymmetric aldol reaction with propionate 20 prepared from Masamune’s chiral 
auxiliary [19]. anti-Aldol 21 was prepared via enolization of ester with dicyclohexylboron triflate and 
triethylamine at −78 °C (Scheme 6) [20]. The absolute configuration at the two newly formed 
stereogenic centers was assigned after conversion of the aldol adduct 21 to the corresponding 
carboxylic acid C (58% yield for two steps) [21]. 
 
Scheme 6. Synthesis of carboxilyc acid C. 
Despite the previous results on the aldol reaction with propionate derived from Masamune’s 
auxiliary described in the literature [19], we decided to confirm the anti relative configuration via 
conversion of the carboxylic acid obtained from ent-21 to the corresponding acetonide 22, after 
reduction with LiAlH4 and treatment with 2,2-dimethoxypropane under acid catalysis (40% overall 
yield). The large coupling constant (3J = 11.6 Hz) observed between Ha and Hb in 22 revealed their 
trans disposition which translates to the expected anti configuration in the corresponding carboxylic 
acid (Scheme 7). 
 
Scheme 7. Conversion of ent-21 to acetonide 22.  
The absolute configuration of the two newly generated stereogenic centers in ent-21 was assigned 
via the corresponding Mosher esters 23 and 24, prepared from (R)- and (S)-α-methoxy-α- 
trifluoromethylphenylacetyl chloride (MTPACl), respectively (Scheme 8). Analyses of the 1H-NMR 
spectra for Mosher esters 23 and 24 revealed ΔδS − R < 0 for H14, H15, H16 and H19 (up to −0.12 ppm) 
and positive values for H5 (+0.05 ppm) which translate to R configuration for both the carbinolic 
carbon and the methine carbon α to the carbonyl group in ent-21 (Table 2) [22–24]. 
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Scheme 8. Preparation of the MTPA esters of ent-21.  
Table 2. Chemical shifts and ΔδS − R values for MTPA esters derived from ent-21. 
 
H  
(S)-MTPA Ester (23) (R)-MTPA Ester (24) Δ (δS − δR) δH (ppm) Multiplicity (J) δH (ppm) Multiplicity (J) 
H-5 1.98 s 1.93 s +0.053 
H-14 0.90 d (3H, J = 7.4) 1.02 d (3H, J = 7.2) −0.12 
H-15 5.73 d (1H, J = 5.1) 5.76 d (1H, J = 5.1) −0.034 
H-16 4.04 m (1H) 4.06 m (1H) −0.02 
H-19 1.07 d (3H, J = 6.9) 1.10 d (3H, J = 6.8) −0.036 
H-37/38 2.37 s (6H) 2.37 s (6H) −0.025 
H-39 2.20 s (3H) 2.21 s (3H) −0.005 
The preference for the anti stereochemistry observed for the major aldol product requires a 
kinetically controlled approach of the E-boron enolate Re face to the Re face of the aldehyde according 
to a 6-membered Zimmerman-Traxler transition state model. The stabilizing interaction involving the 
electron-deficient N-sulfonylmesityl group and the electron-rich double bond of the boron enolate can 
be accommodated in the transition state corresponding to the Re/Re topology while for the Si/Si 
topology which would lead to the diastereoisomeric anti aldol product, a destabilizing interaction 
develops between the pseudoaxial cyclohexyl group and the N-mesityl group of the N-mesitylsulfonyl 
norephedrine chiral auxiliary (Scheme 9). 
Mar. Drugs 2015, 13 3316 
 
 
 
Scheme 9. Proposed transition state model for the aldol reaction. 
With the three key fragments in hands, we initiated the assembly of the structure assigned for 
lyngbyabellin M (4) by coupling the carboxylic acid C with thiazole B which required the protection 
of the secondary alcohol in C as the corresponding terc-butyldimethylsilyl (TBS) ether, hydrolysis to 
the carboxylic acid, followed by coupling with thiazole B. After purification, the corresponding ester 
25 was obtained in 77% yield as a single diastereoisomer over 3 steps, as indicated by the analysis of 
the1H- and 13C-NMR spectra. In order to install thiazole A, a chemoselective hydrolysis of the methyl 
ester in 25 was required which was accomplished using hydroxytrimethyltin in 1,2-dichloroethane 
without any indication of epimerization by 1H- and 13C-NMR analyses [25–27]. The corresponding 
carboxylic acid was prepared from 25 and it was coupled to thiazole A via the EDC/DMAP protocol to 
afford 26 in 83% yield over two steps (Scheme 10). 
 
Scheme 10. Final steps in the total synthesis of lyngbyabellin M (4). 
Comparison of the NMR data of the synthetic sample of lyngbyabellin M (4) prepared after 
deprotection of the TBS group in 26 with HF/pyridine with those available in the literature for 
lyngbyabellin M (4) revealed almost complete match except for C-13, C-14, C-15, C-16, C-20 and C-21. 
Personal information provided by Gerwick and coworkers after completion of our work provided 
revised 13C-NMR data for natural lyngbyabelin M (4) which nicely fit those obtained for the synthetic 
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sample thus confirming the 2S,3S,14R,20S configuration proposed for the natural product by 
spectroscopic analysis and chemical correlation (Table 3). 
Table 3. Comparison of the 13C-NMR data for natural (CDCl3, 125 MHz) and synthetic 
(CDCl3, 125 MHz) lyngbyabellin M. 
Carbon 
Natural Lyngbyabellin M * 
δ (ppm) 
Synthetic Lyngbyabellin M 
δ (ppm) 
1 174.4 174.3 
2 44.4 44.4 
3 75.4 75.3 
4 34.4 34.4 
5 21.5 21.5 
6 50.0 49.9 
7 90.8 90.8 
8 37.7 37.6 
9 15.0 14.9 
10 161.8 161.7 
11 147.6 147.5 
12 128.2 128.2 
13 171.2 (172.1) ** 172.1 
14 70.30 (70.05) ** 70.0 
15 70.26 (70.15) ** 70.2 
16 161.7 (160.6) * 160.5 
17 145.9 145.7 
18 129.2 129.1 
19 170.5 170.4 
20 77.5 (77.1) ** 77.2 
21 34.4 (34.2) ** 34.3 
22 19.5 19.4 
23 16.8 16.7 
24 61.8 61.7 
25 14.7 14.6 
* Spectroscopic data as appeared in [10]; ** Revised data by Gerwick and coworkers [28]. 
Although synthetic lyngbyabellin M (4) displayed the same absolute configuration as that originally 
proposed by Gerwick and coworkers for the natural product, the synthetic sample was shown to be 
dextrorotatory ([α]D25 = +12 (c = 0.5, MeOH)) while natural lyngbyabellin M was reported as 
levorotatory ([α]D25 = −4.5 (c =0.5, MeOH)). We are presently not able to explain this discrepancy  
since a sample of the natural product was not available for us to compare natural and synthetic 
lyngbyabellins M by chiral HPLC or other chiroptical techniques. 
3. Experimental Section 
Reagents and solvents were commercial grade and were used as supplied except when specified in 
the experimental procedure. Triethylamine and dichloromethane were distilled from calcium hydride 
and tetrahydrofuran was distilled from Na/benzophenone. Reactions were monitored by thin layer 
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chromatography analysis using Merck Silica Gel 60 F-254 thin layer plates. Flash column 
chromatography was performed on Acros silica gel 60, 0.040–0.063 mm. 1H NMR and 13C NMR data 
were recorded on a Varian Inova (500 MHz for 1H and 125 MHz for 13C NMR) or Bruker Avance  
(250 MHz for 1H and 62.5 MHz for 13C NMR) spectrometers using as internal standard the residual 
nondeuterated solvent (CHCl3) or TMS (1H NMR). High resolution mass spectra (HRMS) for novel 
compounds were measured on a Waters XEVO Quadrupole-Time of Flight (Q-TOF) spectrometer 
(ESI) or in a Waters Premier (EI). Infrared spectra (IR) were obtained on iS5 spectrometer and 
absorptions are reported in reciprocal centimeters. Melting points were recorded on an Electrothermal 
9100 melting point apparatus and were uncorrected. 
(R)-Ethyl 2-(2,2-dimethyl-1,3-dioxolan-4-yl)thiazole-4-carboxylate (8). To a stirred solution of  
L-cysteine ethyl ester hydrochloride (4.28 g, 23 mmol) and triethylamine (3.37 mL, 1.1 equivalent) in 
ethanol (66 mL), a solution of freshly prepared (R)-(+)-glyceraldehyde acetonide [29,30] (2.86 g,  
22 mmol) in ethanol (10 mL) was added. After stirring for 5 h at room temperature, the solvent was 
evaporated under reduced pressure. The crude product was dissolved in ether and washed with water 
(20 mL) and brine (15 mL). The organic phase was dried over MgSO4 and the solvent evaporated 
under reduced pressure. A colorless oil was obtained which was stirred in CH3CN (130 mL) in the 
presence of MnO2 (30.2 g, 20 equiv.) at 60 °C. The reaction progression was followed by TLC and 
after 48 h the crude mixture was filtered over Celite. Solvent evaporation under reduced pressure was 
followed by purification by column chromatography on silica gel, with hexanes–ethyl acetate (7:3) 
mixture as the eluent. An orange oil was obtained (2.951 g, 11.44 mmol) in 52% yield. IR (cm−1, 
ATR): 2986, 1719, 1372, 1208; 1H NMR (250 MHz, CDCl3): δ 8.19 (s, 1H), 5,43 (dd, 1H, J = 6.7 and 
5.1 Hz), 4.52-4.36 (m, 3H), 4.10 (dd, 1H, J = 8.8 and 5.1 Hz), 1.58 (s, 3H), 1.46 (s, 3H), 1.40 (t, 3H,  
J = 7.1 Hz); 13C NMR (62.5 MHz, CDCl3): δ 172.8, 160.5, 146.7, 126.9, 110.4, 74.7, 69.6, 60.6, 25.7, 
24.4, 13.7. HRMS (ESI/+, m/z): Calcd for: C11H15NO4S, 258.0800; found: 258.0804; [α]D25 = +46 
(CH2Cl2, 1.07). 
(R)-Ethyl 2-(1,2-dihydroxyethyl)thiazole-4-carboxylate (A). To a stirred solution of ester 8 (2.01 g,  
7.8 mmol) in ethanol (30 mL), Amberlist 15 (10% m/m, 0.20 g) was added. The reaction progression 
was followed by TLC and after 3 h, the mixture was filtered and the solvent was evaporated under 
reduced pressure. The crude product was recrystallized from hexanes–ethyl acetate (2:1) and a white 
solid (1.19 g, 5.46 mmol) was obtained in 70% yield. MP 152–153 °C; IR (cm−1, ATR): 3293, 3114, 
1716, 1507, 1234, 1052; 1H NMR (250 MHz, MeOD): δ 8.32 (s, 1H), 4.96 (dd, 1H, J = 6.0 and  
3.8 Hz), 4.37 (q, 2H, J = 7.1 Hz), 3.93 (dd, 1H, J = 11.5 and 3.8 Hz), 3.76 (dd, 1H, J = 11.5 and  
6.0 Hz), 1.38 (t, 3H, J = 7.1 Hz); 13C NMR (62.5 MHz, MeOD): δ 177.2, 162.8, 147.7, 129.2, 73.6, 
67.2, 62.4, 14.6. HRMS (ESI/+, m/z): Calcd: C8H11NO4S, 218.0487; Found: 218.0475; [α]D25 = +59  
(MeOH, 1.15). 
(S)-Methyl 2-(1-hydroxy-2-methylpropyl)thiazole-4-carboxylate (Thiazole B). To a solution of 
thiazol 1314 (0.503 g, 1.85 mmol) in anhydrous methanol (25 mL) was added dibutyltinoxide (2.30 g,  
9.38 mmol). The suspension was stirred 12 h under reflux and the reaction course was monitored by 
TLC. The solids were removed by filtration and the solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography in silica gel using an isocratic mixture of  
hexanes-ethyl acetate (7:3, V/V). A colorless solid was isolated in 71% yield (0.283 g, 1.31 mmol). MP 
50–52 °C; IR (cm−1, ATR): 3279, 2968, 1735, 1714, 1212. 1H NMR (250 MHz, CDCl3): δ 8.11 (s, 1H), 
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4.86 (d, J = 4.7 Hz, 1H), 3.90 (s, 3H), 3.36 (br s, 1H), 2.29–2.15 (m, 1H), 0.98 (d, J = 6.8 Hz, 3H), 
0.90 (d, J = 6.8 Hz, 3H). 13C NMR (62.5 MHz, CDCl3): δ 176.2, 161.9, 146.2, 127.5, 76.5, 52.4, 34.9, 
18.8, 16.2. HRMS (ESI/+, m/z): Calcd: C9H14NO3S, 216.0694; Found: 216.0703. [α]D25 = −27  
(CHCl3, 0.78). 
5,5-Dichlorohexan-1-ol (16). To a flask containing 4Å molecular sieves (15 g) was added methanol 
(70 mL) and hydrazine monohydrate (5 mL, 5 equiv.) were added successively with stirring. After  
20 min, 5-hexen-2-one (18, 2.4 mL, 20.4 mmol) was added dropwise to the reaction mixture and the 
mixture was stirred overnight. Molecular sieves were filtered off and washed with ethanol. The 
combined filtrate was concentrated under reduced pressure and the excess hydrazine was further 
removed by azeotropic distillation with ethanol under reduced pressure. The crude product was 
dissolved in methanol (60 mL). A solution of anhydrous copper(II) chloride (12.1 g, 6 equiv.) and 
triethylamine (8.5 mL, 3 equiv.) in methanol (120 mL) was prepared after stirring for 10 min. at 20 °C 
and cooled to 0 °C. To this solution was added dropwise the above hydrazone solution over 15 min. 
The cooling bath was removed and stirring was continued for 2 h. The reaction mixture was quenched 
by the addition of aqueous ammonia solution (3.5% v/v, 10 mL) and the mixture was extracted with 
cold pentane (3 × 150 mL), washed with brine, dried (Na2SO4), and carefully concentrated under 
reduced pressure. A volatile colorless oil (1.74 g, 11.4 mmol) was obtained in 56% crude yield.  
1H NMR (250 MHz, CDCl3): δ 5.94–5.74 (m, 1H), 5.16–4.95 (m, 2H), 2.50-2.36 (m, 2H), 2.35–2.25 
(m, 2H), 2.17 (s, 3H); 13C NMR (62.5 MHz, CDCl3): δ 136.4, 115.6, 90.1, 48.8, 37.4, 29.9. A round 
bottomed flask equipped with a nitrogen inlet containing the colorless oil above, 9-borabicylcononane 
solution (0.5 M in THF, 24 mL, 11.6 mmol) was added via syringe. After stirring 2 h at room 
temperature, water (10 mL) was added, followed by sodium perborate (4.3 g, 3 equiv.). The mixture 
was vigorously stirred for 2 h and extracted with diethyl ether. The combined organic phase was 
washed with saturated NaCl solution (10 mL) and dried (MgSO4), and the product was purified by 
column chromatography on silica gel using hexanes–ethyl acetate (6:4) mixture as the eluent. A 
colorless oil (1.325 g, 7.75 mmol) was obtained in 38% overall yield from 18. IR (cm−1, ATR): 3345, 
2936, 2873, 1440, 1380, 1169, 1071, 1050; 1H NMR (250 MHz, CDCl3): δ 3.60 (t, 2H, J = 6.3 Hz), 2.82 
(br s, 1H), 2.23–2.13 (m, 2H), 2.10 (s, 3H), 1.75–1.49 (m, 4H); 13C NMR (62.5 MHz, CDCl3): δ 90.7, 
62.2, 49.5, 37.3, 31.8, 22.1. 
5,5-Dichlorohexanal (17). To a mixture of pyridinium chlorochromate (0.97 g, 2 equiv.) and 4Å 
molecular sieves (1 g) in DCM (40 mL) was added a solution of the alcohol 16 (0.38 g, 2.2 mmol) in 
DCM (5 mL). The mixture was then stirred at room temperature for 1 h and the residue was filtered 
through a short pad of Florisil and silica gel, washed with DCM and the solvent was evaporated under 
reduced pressure. A volatile colorless oil (0.82 g, 85% crude yield) was obtained and used without 
purification in the next step. IR (cm−1, ATR): 2932, 2726, 1723, 1448, 1381, 1171; 1H NMR  
(250 MHz, CDCl3): δ 9.78 (t, 1H, J = 1.3 Hz), 2.54 (td, 2H, J = 7.1 and 1.3 Hz), 2.26–2.18 (m, 2H), 
2.15 (s, 3H), 2.07–1.93 (m, 2H); 13C NMR (62.5 MHz, CDCl3): δ 201.3, 90.0, 48.7, 42.8, 37.3, 18.3. 
(2S,3S)-7,7-Dichloro-3-hydroxy-2-methyloctanoic acid (C). To an oven-dried round-bottomed 
flask, a stirred solution of (1S,2R)-20 (0.500 g, 1.04 mmol) and triethylamine (0.35 mL, 2.4 equiv.)  
in DCM (5 mL) was added and cooled to −78 °C. A solution of freshly prepared c-Hex2BOTf (1.0 M 
in hexane, 2.3 mL, 2.2 equiv.) was added dropwise via syringe over 15 min. The resulting solution was 
stirred at −78 °C for 30 min. and a solution of aldehyde 17 (0.21 g, 1.2 equiv.) in DCM (2 mL) was 
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added dropwise. The reaction mixture was stirred at −78 °C for 2 h and allowed to warm to room 
temperature over 1 h. Then, the reaction mixture was quenched by the addition of phosphate buffer 
solution (pH 7, 5 mL), followed by MeOH (15 mL) and 30% aqueous H2O2 (2 mL, careful addition). 
The mixture was vigorously stirred overnight and then concentrated under reduced pressure. The 
residue was partitioned between water (15 mL) and DCM (30 mL). The aqueous layer was extracted 
with DCM and the combined organic layer was concentrated. The aldol product was isolated by 
chromatography on silica gel using hexanes-ethyl acetate (8:2) as eluent. A viscous colorless oil 
containing a small quantity of cyclohexanol was dissolved in a water-MeOH-THF solution (1:1:1,  
9 mL) and LiOH·H2O (126 mg, 5 equiv.) was added. The mixture was stirred overnight at room 
temperature and poured into water (10 mL). After extraction with ether to recover the chiral auxiliary, 
the aqueous layer was acidified with 1M HCl to pH 2 and extracted with DCM. The organic layer was 
washed with brine and dried with Na2SO4. After solvent concentration under reduced pressure, the 
product was purified by chromatography on a short pad of silica gel with gradient. The nonpolar 
products were removed with hexanes-ethyl acetate (7:3) and the acid C was removed with ethyl acetate to 
give a viscous colorless oil (0.145 g, 0.60 mmol) in 58% yield over two steps. IR (cm−1, ATR): 3344, 
2984, 2964, 1694, 1208; 1H NMR (250 MHz, CDCl3): δ 3.65–3.85 (m, 1H), 2.57 (qt, 1H, J = 7.1),  
2.28–2.18 (m, 2H), 2.14 (s, 3H), 1.96–1.48 (m, 4H), 1.24 (d, 3H, J = 7.1); 13C NMR (62.5 MHz, 
CDCl3): δ 180.8, 90.5, 73.0, 49.5, 45.3, 37.3, 33.6, 21.9, 14.1. HRMS (ESI/−, m/z): Calcd: C9H16Cl2O3, 
241.0398; Found: 241.0439. [α]D25 = −6 (MeOH, 1.00). 
Methyl-2-((S)-1-(((2S,3S)-3-((tert-butyldimethylsilyl)oxy)-7,7-dichloro-2-methyloctanoyl)oxy)-2-
methylpropyl)thiazole-4-carboxylate (25). Carboxylic acid C (0.14 g, 0.60 mmol) was dissolved  
in DCM (3 mL) and cooled to 0 °C. To this solution, triethylamine (0.5 mL, 6 equiv.) and  
tert-butyldimethylsilyl triflate (0.36 mL, 2.6 equiv.) were added. The mixture was stirred for 2 h at  
0 °C. Then potassium carbonate (0.41 g, 5.85 mmol), water (4 mL), MeOH (4 mL), and THF (4 mL) 
were added, and the mixture was stirred for 6 h at room temperature. To this solution ethyl acetate  
(20 mL) and brine (5 mL) were added and the mixture was acidified with 1M HCl (pH 2). The organic 
layer was separated, and the aqueous layer was extracted with ethyl acetate (2 × 20 mL). The 
combined organic layers were dried (Na2SO4), and concentrated under reduced pressure. The 
remaining oil (0.21 g) was dissolved in DCM (3 mL) and EDC (0.13 g, 1.2 equiv.), thiazole B (0.14 g, 
1.1 equiv.) and catalytic quantity of DMAP were added. The mixture was stirred overnight at room 
temperature and quenched by addition of brine (5 mL), followed by extraction with ethyl acetate  
(3 × 20 mL). The organic layer was dried with Na2SO4 and after solvent evaporation under reduced 
pressure, the crude product was purified by chromatography on silica gel using hexanes-ethyl acetate 
(7:3). A colorless oil (0.256 g, 0.462 mmol) was obtained in 77% yield for two steps. IR (ATR, cm−1): 
2956, 2931, 2856, 1744, 1244, 1107; 1H NMR (250 MHz, CDCl3): δ 8.12 (s, 1H), 6.03 (d, 1H,  
J = 5.3 Hz), 4.13–4.03 (m, 1H), 3.92 (s, 3H), 2.86–2.71 (m, 1H), 2.48–2.33 (m, 1H), 2.10 (s, 3H),  
1.84–1.12 (m, 9H), 0.95 (s, 3H), 0.93 (s, 3H), 0.83 (s, 9H), 0.07 (s, 3H), 0.01 (s, 3H); 13C NMR  
(62.5 MHz, CDCl3): δ 172.9, 170.5, 161.7, 146.9, 127.2, 90.5, 77.1, 72.6, 52.4, 49.7, 45.5, 37.3, 33.5, 
32.1, 25.7, 21.7, 18.6, 17.9, 17.0, 10.9, −4.6, −4.7. HRMS (ESI/+, m/z): Calcd: C24H42Cl2NO5SSi, 
554.1930; Found: 554.1943. [α]D25 = −10 (CH2Cl2, 0.8). 
(R)-2-(4-(Ethoxycarbonyl)thiazol-2-yl)-2-hydroxyethyl-2-((S)-1-(((2S,3S)-3-((tert-butyldimethylsilyl)oxy)- 
7,7-dichloro-2-methyloctanoyl)oxy)-2-methylpropyl)thiazole-4-carboxylate (26). Carboxylic ester 25 
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(88.7 mg, 0.16 mmol) was dissolved in 1,2-dichloroethane (3 mL) and after addition of trimethyltin 
hydroxide (0.18 g, 6 equiv.), the mixture was heated at 70 °C until the reaction was complete by TLC 
analysis. After 2 h, the mixture was concentrated in vacuo, and the residue was taken up in ethyl acetate 
(15 mL). The organic layer was washed successively with HCl (5% v/v, 5 mL) and brine (5 mL) and dried 
over sodium sulfate. Removal of the solvent in vacuo afforded the corresponding carboxylic acid as 
colorless oil (73 mg) which was dissolved in DCM (2 mL). To this solution EDC (17 mg, 1.1 equiv.), 
compound A (17 mg, 1.1 equiv.) and catalytic quantity of DMAP were added. The mixture was stirred 
overnight at room temperature and quenched by addition of brine (5 mL), followed by extraction with 
ethyl acetate (3 × 20 mL). The organic layer was dried with Na2SO4 and after solvent concentration, 
the product was purified by preparative thin layer chromatography on silica gel using chloroform-ethyl 
acetate (7:3). A colorless oil (0.0982 g, 0.133 mmol) was obtained in 83% yield. IR (ATR, cm−1): 2956, 
2931, 2856, 1744, 1244, 1107; 1H NMR (250 MHz, CDCl3): δ 8.17 (s, 2H), 5.98 (d, 1H, J = 5.6 Hz), 
5.47 (dd, 1H, J = 6.9 and 3.2 Hz), 4.88 (dd, 1H, J = 11.5 and 3.2 Hz), 4.62 (dd, 1H, J = 11.5 and 7.4 
Hz), 4,41 (q, 2H, J = 7.1 Hz), 4.12–4.04 (m, 1H), 2.83–2.76 (m, 1H), 2.43–2.34 (m, 1H), 2.13 (s, 3H), 
1.83–1.49 (m, 4H), 1.40 (t, 3H, J = 7.2 Hz), 1.18 (d, 3H, J = 7.0 Hz), 0.96 (dd, 6H, J = 6.2 Hz), 0.84  
(s, 9H), 0.08 (s, 3H), 0.01 (s, 3H); 13C NMR (62.5 MHz, CDCl3): δ 173.0, 171.9, 170.9, 161.3, 161.1, 
147.2, 146.0, 128.3, 127.9, 90.6, 77.0, 72.7, 70.5, 68.9, 61.5, 49.7, 45.4, 37.4, 33.5, 32.2, 29.6, 25.7, 
21.6, 18.6, 17.9, 17.2, 14.3, 11.0, −4.6, −4.7. HRMS (ESI/+. m/z): Calcd: C31H49Cl2N2O8S2Si. 
739.2076; Found: 739.2107; [α]D25 = +23 (CHCl3, 0.65). 
(R)-2-(4-(Ethoxycarbonyl)thiazol-2-yl)-2-hydroxyethyl 2-((S)-1-(((2S,3S)-7,7-dichloro-3-hydroxy-2-
methyloctanoyl)oxy)-2-methylpropyl)thiazole-4-carboxylate (4). A teflon test tube was charged with a 
solution of compound 26 (0.0210 g, 0.0284 mmol) in THF (1 mL) and a solution of pyridine-HF (70%, 
0.15 mL, 250 equiv.) was added. The solution was stirred for 24 h at room temperature and the 
reaction mixture was dissolved in ethyl acetate (20 mL), washed with water (5 mL), brine (5 mL) and 
dried over Na2SO4. After solvent concentration under reduced pressure, the product was purified by 
preparative thin layer chromatography on silica gel using chloroform–ethyl acetate (6:4). A colorless 
oil (0.0135 g, 0.0216 mmol) was obtained in 76% yield. IR (ATR, cm−1): 3337, 3118, 2967, 2935, 
1731, 1485, 1325, 1210, 1170, 1099; 1H NMR (500 MHz, CDCl3): δ 8.30 (s, 1H), 8.18 (s, 1H), 5.99 
(d, 1H, J = 3.7 Hz), 5.42 (dd, 1H, J = 9.1 and 2.5 Hz), 4.95 (dd, 1H, J = 11.3 and 2.5 Hz), 4.43 (q, 2H,  
J = 7.1 Hz), 4.31 (dd, 1H, J = 11.3 and 9.0 Hz), 3.81 (q, 2H, J = 5.1 Hz), 2.89–2.81 (m, 1H), 2.39–2.19 
(m, 4H), 2.16 (s, 3H), 1.96–1.83 (m, 4H), 1.41 (t, 3H, J = 7.1 Hz), 1.26 (d, 4H, J = 7.1 Hz), 1.15  
(d, 3H, J = 6.7 Hz), 1.00 (d, 3H, J = 7.1 Hz); 13C NMR (125 MHz, CDCl3): δ 174.4, 172.1, 170.5, 
161.7, 160.5, 147.5, 145.7, 129.1, 128.2, 90.8, 75.4, 70.2, 70.2, 61.7, 49.9, 37.7, 34.5, 34.3, 21.5, 19.4, 
16.7, 15.0, 14.6. HRMS (ESI/+. m/z): Calcd: C25H35Cl2N2O8S2: 625.1212, Found: 625.1185, [α]D25 = +12 
(MeOH, 0.5). 
4. Conclusions 
The first total synthesis of (+)-lyngbyabellin M (4) was described involving the coupling of two 
chiral thiazole intermediates and a chiral carboxylic acid stereoselectively prepared in three steps from 
commercially available Masamune’s chiral auxiliary via an anti selective aldol reaction. A transition 
state model to rationalize the anti preference was proposed based on the preferential formation of and 
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(E)-boron enolate and the intervenience of a Zimmerman-Traxler approach to minimize steric 
repulsion between the N-sulfonylmesityl group in the chiral auxiliary and the cyclohexyl groups of the 
boron enolate in the transition state. (+)-Lyngbyabellin M (4) was prepared in 28% overall yield from 
commercially available Masamune’s chiral auxiliary (1S,2R)-propionate 20, and its spectroscopy 
identity to natural lyngbyabellin M was confirmed by 1H- and 13C NMR spectroscopies. The difference 
observed in the specific optical rotation of synthetic and natural lyngbyabellin M was assigned to the 
presence of levorotatory impurities in the natural sample. 
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